Browser does not support script.
We make a powerful contribution to understanding how genetic abnormalities within cancer cells lead to disease. Through Birmingham’s Cancer Research UK Clinical Trials Unit- one of Europe’s leading clinical trials unit- we use this information to design and rigorously assess new and proven cancer treatments. In so doing, we will play a significant role in accelerating the ultimate control of cancer.
Scientists set to benefit from one of the biggest grants awarded by Cancer Research UK
New molecular mechanism revealed for genetic mutations in aggressive cancer cells
Scientists closer to understanding the role of certain genes in breast cancer
MP dons lab coat to learn how research saves lives
Life Sciences in Six - Dr Joanna Parish
My story: Graham Silk
Precision Medicine: Diagnostic medical genetics
Dr Andrew Peet - Support our brain cancer in children research
Posted 15 March 2018
Scientists in the College of Medical and Dental Sciences have been awarded nearly £3 million from Cancer Research UK to investigate cancers that are resistant to treatment.
Posted 12 March 2018
Dr Rachel Bayley, a Research Fellow within the Institute of Cancer and Genomic Sciences, will represent the University of Birmingham and join 600 of the most qualified young scientists from all over the world at the prestigious the 68th Lindau Nobel Laureate Meeting in Lindau, Germany, in June 2018.
Posted 21 February 2018
Professors Conny Bonifer and Peter Cockerill have found a way to restore healthy blood production in acute myeloid leukaemia (AML) by helping cells stuck in an immature state to develop into mature blood cells, as Bloodwise reports.
Posted 16 February 2018
Under the UK-India Education and Research Initiative (UKIERI), Dr Sovan Sarkar has been awarded the UKIERI DST Thematic Partnership Award with Dr Dhiraj Kumar at the International Centre for Genetic Engineering and Biotechnology (ICGEB) in New Delhi, India.
Professor Pamela Kearns, Director of the Cancer Research UK Clinical Trials Unit, writes for the Birmingham Brief on how current innovations in cancer medicines are not reaching children.
View all news